Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.

PMID: 35780651 ·

S, i, m, e, n, g, , Z, h, u, ;, , M, a, r, i, s, s, a, , G, i, l, b, e, r, t, ;, , I, n, d, r, i, n, , C, h, e, t, t, y, ;, , F, a, r, z, a, n, , S, i, d, d, i, q, u, i

RevistaInternational journal of medical informatics
Año
PMID35780651

Resumen

Machine learning (ML), a type of artificial intelligence (AI) technology that uses a data-driven approach for pattern recognition, has been shown to be beneficial for many tasks across healthcare. To characterize the commercial availability of AI/ML applications in the clinic, we performed a detailed analysis of AI/ML-enabled medical devices approved/cleared by the US Food and Drug Administration (FDA) by June 2021. The publicly available approval letters by the FDA on 343 AI/ML-enabled medical

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑